Bernat Crosas
Barcelona Science Park
Barcelona, CT 08028, Spain
Barcelona, CT 08028, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Proteasome dysfunction underlies HERC2-linked neurodevelopmental disorder with Angelman-like clinical features.
Journal: Cell death discovery
Published: January 26, 2026
Aptamer-Hytac Chimeras for Targeted Degradation of SARS-CoV-2 Spike-1.
Journal: Cells
Published: August 31, 2024
Induction of the Inflammasome by the SARS-CoV-2 Accessory Protein ORF9b, Abrogated by Small-Molecule ORF9b Homodimerization Inhibitors.
Journal: Journal of medical virology
Published: June 11, 2024
The Potential of Proteolytic Chimeras as Pharmacological Tools and Therapeutic Agents.
Journal: Molecules (Basel, Switzerland)
Published: October 27, 2020
How the 26S Proteasome Degrades Ubiquitinated Proteins in the Cell.
Journal: Biomolecules
Published: June 15, 2019
A C2HC zinc finger is essential for the RING-E2 interaction of the ubiquitin ligase RNF125.
Journal: Scientific reports
Published: October 30, 2015
Cold Temperature Induces the Reprogramming of Proteolytic Pathways in Yeast.
Journal: The Journal of biological chemistry
Published: October 16, 2015
Rpn10 monoubiquitination orchestrates the association of the ubiquilin-type DSK2 receptor with the proteasome.
Journal: The Biochemical journal
Published: May 26, 2015
An intrinsically disordered region of RPN10 plays a key role in restricting ubiquitin chain elongation in RPN10 monoubiquitination.
Journal: The Biochemical journal
Published: January 05, 2015
Deubiquitinating enzyme inhibitors and their potential in cancer therapy.
Journal: Current cancer drug targets
Published: May 03, 2014
Ubiquitin signaling: extreme conservation as a source of diversity.
Journal: Cells
Published: March 20, 2014
Last Updated: 09/26/2026